A research group is applying the investigative and predictive capabilities of artificial intelligence (AI) to better identify which patients with early stage oral squamous cell carcinoma will require chemotherapy, radiation, or other…

A low dose of the semisynthetic drug naltrexone has been found to provide pain relief for patients with orofacial and chronic pain, and without risk of addiction, a new study reports. The paper, “Use of Low-Dose Naltrexone in the Management…

Eligible organizations can apply for a new grant established by Delta Dental of Arkansas Foundation.

Crest and Oral-B Kids are teaming up with actor Miles Brown on a new Conquer Cavities 2Gether initiative.